Event Details

Clene Inc. Presentation of CNM-Au8 Topline Data From the HEALEY ALS Platform Trial

Oct 3, 2022

Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2024 Clene Nanomedicine, Inc. - All rights reserved